Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Erleada (apalutamide) for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

Erleada™ is a US Food and Drug Administration (FDA) approved drug for the treatment of non-metastatic castration-resistant prostate cancer. Image courtesy of Janssen.

  • Erleada
  • Erleada
  • Erleada

Go Top